References
- FletcherCPetoRThe natural history of chronic airflow obstructionBr Med J19771607716451648871704
- WareJHDockeryDWLouisTALongitudinal and cross-sectional estimates of pulmonary function decline in never-smoking adultsAm J Epidemiol199013246857002403109
- CasanovaCde TorresJPAguirre-JaimeAThe progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohortAm J Respir Crit Care Med201118491015102121836135
- VestboJEdwardsLDScanlonPDChanges in forced expiratory volume in 1 second over time in COPDN Engl J Med2011365131184119221991892
- KestenSCelliBDecramerMAdverse health consequences in COPD patients with rapid decline in FEV1–evidence from the UPLIFT trialRespir Res20111212921955733
- AnthonisenNRConnettJEKileyJPEffects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health StudyJAMA199427219149715057966841
- Ramirez-VenegasASansoresRHQuintana-CarrilloRHFEV1 decline in patients with chronic obstructive pulmonary disease associated with biomass exposureAm J Respir Crit Care Med20141909996100225172140
- NishimuraMMakitaHNagaiKAnnual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20121851445222016444
- Sanchez-SalcedoPDivoMCasanovaCDisease progression in young patients with COPD: rethinking the Fletcher and Peto modelEur Respir J201444232433124696115
- ChoiJKPaekDLeeJONormal predictive values of spirometry in Korean populationTuberc Respir Dis2005583230242
- PellegrinoRViegiGBrusascoVInterpretative strategies for lung function testsEur Respir J200526594896816264058
- HardieJABuistASVollmerWMRisk of over-diagnosis of COPD in asymptomatic elderly never-smokersEur Respir J20022051117112212449163
- VestboJHurdSSAgustiAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
- JanssensJPPacheJCNicodLPPhysiological changes in respiratory function associated with ageingEur Respir J199913119720510836348
- BrandliOSchindlerCKunzliNLung function in healthy never smoking adults: reference values and lower limits of normal of a Swiss populationThorax19965132772838779131
- SandfordAJChaganiTWeirTDSusceptibility genes for rapid decline of lung function in the lung health studyAm J Respir Crit Care Med2001163246947311179124
- TantucciCModinaDLung function decline in COPDInt J Chron Obstruct Pulmon Dis20127959922371650
- JenkinsCRJonesPWCalverleyPMEfficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH studyRespir Res2009105919566934
- DecramerMCelliBKestenSEffect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trialLancet200937496961171117819716598
- CelliBRThomasNEAndersonJAEffect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH studyAm J Respir Crit Care Med2008178433233818511702
- ThomsenLHDirksenAShakerSBAnalysis of FEV1 decline in relatively healthy heavy smokers: implications of expressing changes in FEV1 in relative termsCOPD20141119610424111638
- MoriceAHCelliBKestenSCOPD in young patients: a pre-specified analysis of the four-year trial of tiotropium (UPLIFT)Respir Med2010104111659166720724131
- TashkinDPLiNHalpinDAnnual rates of change in pre- vs post-bronchodilator FEV1 and FVC over 4 years in moderate to very severe COPDRespir Med2013107121904191123972968
- TashkinDPLiNKleerupECAcute bronchodilator responses decline progressively over 4 years in patients with moderate to very severe COPDRespir Res20141510225175805